|
⚲
|
| Keyboard |
| Bigham Michael
✚
|
|
|---|---|
| CIK # | 0001216917 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001216917] | |
| 4 | [0001216917] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Transcept Pharmaceuticals Inc | |
| Bigham Michael | |
| Frazier Lifesciences Acquisition Corp | |
| Adamas Pharmaceuticals Inc | |
| Supernus Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2023-09-21 | Disposed to issuer | 228,750 | ||
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2023-09-21 | Disposed to issuer | 1,129,282 | ||
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2023-08-09 | Sell | 31,250 | $2.20 | 68,750 |
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2023-08-08 | Grant | 156,250 | $0.00 | |
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2022-12-21 | Sell | 15,750 | $1.99 | 31,342 |
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2022-12-20 | Grant | 45,000 | $0.00 | |
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2022-12-13 | Sell | 31,891 | $1.96 | 62,506 |
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2022-12-12 | Sell | 19,484 | $1.98 | 38,578 |
|
Frazier Lifesciences Acquisition Corp FLAC
Class B Ordinary Shares · derivative
|
2022-11-22 | Option exercise | 30,000 | ||
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2022-10-28 | Sell | 6,000 | $3.47 | 20,820 |
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2022-10-25 | Grant | 30,000 | $0.00 | |
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2022-08-09 | Sell | 28,637 | $2.66 | 76,174 |
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2022-08-08 | Grant | 143,182 | $0.00 | |
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2022-03-15 | Grant | 202,500 | $0.00 | |
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2021-12-15 | Sell | 17,819 | $4.27 | 76,087 |
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2021-12-14 | Sell | 8,622 | $4.37 | 37,678 |
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2021-12-13 | Sell | 5,059 | $4.42 | 22,361 |
|
Adamas Pharmaceuticals Inc ADMS
Stock Option (Right to Buy) · derivative
|
2021-11-24 | Disposed to issuer | 10,000 | ||
|
Adamas Pharmaceuticals Inc ADMS
Stock Option (Right to Buy) · derivative
|
2021-11-24 | Disposed to issuer | 10,000 | ||
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2021-11-24 | Tender | 10,000 | ||
| showing 20 of 83 most recent transactions | |||||